Cargando…

E-Cadherin (CDH1 Gene) Germline Mutations in Gastric Cancer: Evolutions and Innovations

Detalles Bibliográficos
Autores principales:	Corso, Giovanni, Bonanni, Bernardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601113/ https://www.ncbi.nlm.nih.gov/pubmed/33050628 http://dx.doi.org/10.3390/cancers12102920

Ejemplares similares

Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review
por: Corso, Giovanni, et al.
Publicado: (2021)

Frequency of CDH1 Germline Mutations in Non-Gastric Cancers
por: Massari, Giulia, et al.
Publicado: (2021)

Pleiotropic cancer manifestations of germline CDH1 mutations: Risks and management
por: Corso, Giovanni
Publicado: (2022)

Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review
por: Corso, Giovanni, et al.
Publicado: (2020)

CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management
por: Shenoy, Santosh
Publicado: (2019)

Germline CDH1 deletions in hereditary diffuse gastric cancer families
por: Oliveira, Carla, et al.
Publicado: (2009)

Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer
por: Stone, J, et al.
Publicado: (1999)

3D Chromatin Architecture Re-Wiring at the CDH3/CDH1 Loci Contributes to E-Cadherin to P-Cadherin Expression Switch in Gastric Cancer
por: São José, Celina, et al.
Publicado: (2023)

Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin
por: Förster, Alisa, et al.
Publicado: (2021)

Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature
por: Corso, Giovanni, et al.
Publicado: (2012)

E‐cadherin deregulation in breast cancer
por: Corso, Giovanni, et al.
Publicado: (2020)

Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers
por: van der Post, Rachel S, et al.
Publicado: (2015)

Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer
por: Khouzam, Raefa Abou, et al.
Publicado: (2016)

Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients
por: Yamada, Hidetaka, et al.
Publicado: (2009)

Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition, and Implication of CDH23 in Schizophrenia
por: Balan, Shabeesh, et al.
Publicado: (2021)

Germline CDH1 mutations in bilateral lobular carcinoma in situ
por: Petridis, C, et al.
Publicado: (2014)

Clinical spectrum and pleiotropic nature of CDH1 germline mutations
por: Figueiredo, Joana, et al.
Publicado: (2019)

Presymptomatic Identification of CDH1 Germline Mutation in a Healthy Korean Individual with Family History of Gastric Cancer
por: Choi, Hyun-Jung, et al.
Publicado: (2014)

Identification of c.1531C>T Pathogenic Variant in the CDH1 Gene as a Novel Germline Mutation of Hereditary Diffuse Gastric Cancer
por: Norero, Enrique, et al.
Publicado: (2019)

CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer
por: Caldeira, José Roberto F, et al.
Publicado: (2006)

CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer
por: Adib, Elio, et al.
Publicado: (2021)

Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer
por: Ku, Su-Chi, et al.
Publicado: (2022)

Identification and Characterization of CDH1 Germline Variants in Sporadic Gastric Cancer Patients and in Individuals at Risk of Gastric Cancer
por: Garziera, Marica, et al.
Publicado: (2013)

Analysis of E-cadherin (CDH1) Gene Polymorphism and Its Association with Cervical Cancer Risk in Bangladeshi Women
por: Rahman, Md. Abdur, et al.
Publicado: (2023)

Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer
por: Malpeli, Giorgio, et al.
Publicado: (2022)

Frequency and Clinical Characteristics of Unselected Korean Gastric Cancer Patients with a Germline CDH1 V832M Mutation
por: Shin, Saeam, et al.
Publicado: (2020)

Association of e-cadherin gene CDH1 polymorphism -160 C/A with susceptibility to develop vitiligo()
por: Kubelis-López, David Emmanuel, et al.
Publicado: (2023)

CDH1 (E-cadherin) Gene Methylation in Human Breast Cancer: Critical Appraisal of a Long and Twisted Story
por: Bücker, Lara, et al.
Publicado: (2022)

CDH1 Germline Variants in a Tunisian Cohort with Hereditary Diffuse Gastric Carcinoma
por: Ben Aissa-Haj, Jihenne, et al.
Publicado: (2022)

Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers
por: Schrader, K A, et al.
Publicado: (2010)

E-cadherin and K-ras: implications of a newly developed model of gastric cancer
por: Till, Jacob E., et al.
Publicado: (2017)

FOXF1 Inhibits Pulmonary Fibrosis by Preventing CDH2-CDH11 Cadherin Switch in Myofibroblasts
por: Black, Markaisa, et al.
Publicado: (2018)

CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland
por: Jakubowska, Anna, et al.
Publicado: (2010)

Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori
por: Hakkaart, Christopher, et al.
Publicado: (2018)

A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: A case control study in an Italian population
por: Nasri, Soroush, et al.
Publicado: (2008)

Frequency of CDH1, CTNNA1 and CTNND1 Germline Variants in Families with Diffuse and Mixed Gastric Cancer
por: Guerra, Joana, et al.
Publicado: (2023)

A novel de novo CDH1 germline variant aids in the classification of carboxy-terminal E-cadherin alterations predicted to escape nonsense-mediated mRNA decay
por: Krempely, Kate, et al.
Publicado: (2018)

Is Upregulation of BCL2 a Determinant of Tumor Development Driven by Inactivation of CDH1/E-Cadherin?
por: Karch, Inga, et al.
Publicado: (2013)

Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis
por: Kim, Sun A, et al.
Publicado: (2016)

CDH4 suppresses the progression of salivary adenoid cystic carcinoma via E-cadherin co-expression
por: Xie, Jian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dmh2hvqbueju6fa73nppkagqtl